She discusses the current state of evidence on the role of fluid and neurophysiological biomarkers in the early diagnosis of progression of relapsing-remitting MS to secondary progressive MS, and more.
...
He talks about his session at our Advances in Inflammatory Bowel Disease regional meeting in Los Angeles, during which he will speak about the importance of dysplasia surveillance and how dysplasia should...
David Holtzman, MD, talks about the established biomarkers for Alzheimer disease, potential biomarkers being investigated, and how long it may take for these biomarker tests to make it to the bedside.
In this podcast, Christina Y. Ha, MD, provides insight into the prevention and management of Clostridioides difficile infection among patients with inflammatory bowel disease. It is a topic she will be...
In this podcast, Shumei Man, MD, PhD discusses the findings from her recent study, which indicated that shorter thrombolytic door-to-needle times were associated with lower all-cause readmission and lower...
In this podcast, Dr Robbins discusses how the ongoing pandemic has impacted headache medicine thus far, key areas of future research going forward, and what neurologists should keep in mind as the pandemic...
In this podcast, Dr DeLuca discusses the clinical course and prognosis of cognitive impairment in relapsing-remitting multiple sclerosis, as well as cognitive rehabilitation tools that are currently...
In this 12-minute podcast, Vrinda Bhardwaj, MD, from Children's Hospital Los Angeles, reviews the use of elemental and elimination diets for treatment of eosinophilic gastrointestinal diseases in...
Mona Bostick, RDN, LDN, discusses nutrition and the role of multidisciplinary nutrition care for patients with multiple sclerosis. She recently gave a talk on this topic at the 2020 CMSC Virtual Meeting.
...
